# Oral Versus Intravenous Tranexamic Acid

> **NCT04089865** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 400 (actual)

## Conditions studied

- Blood Loss
- Blood Transfusion

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT04089865
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-17
- **Primary completion:** 2021-11-10
- **Final completion:** 2021-11-10
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04089865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04089865, "Oral Versus Intravenous Tranexamic Acid". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04089865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*